- document
-
Handula, M. (author), Beekman, Savanne (author), Konijnenberg, Mark (author), Stuurman, Debra (author), de Ridder, Corrina (author), Bruchertseifer, Frank (author), Morgenstern, Alfred (author), Denkova, A.G. (author), de Blois, Erik (author), Seimbille, Y. (author)Background: The [<sup>177</sup>Lu]Lu-DOTA-TATE mediated peptide receptor radionuclide therapy (PRRT) of neuroendocrine tumors (NETs) is sometimes leading to treatment resistance and disease recurrence. An interesting alternative could be the somatostatin antagonist, [<sup>177</sup>Lu]Lu-DOTA-JR11, that demonstrated better biodistribution...journal article 2023
- document
-
De Swart, Jan (author), Chan, Ho Sze (author), Goorden, M.C. (author), Morgenstern, Alfred (author), Bruchertseifer, Frank (author), Beekman, F.J. (author), de Jong, M. (author), Konijnenberg, Mark W. (author)The combined α-, γ-, and x-ray emitter <sup>213</sup>Bi (half-life, 46 min) is promising for radionuclide therapy. SPECT imaging of <sup>213</sup>Bi is challenging, because most emitted photons have a much higher energy (440 keV) than common in SPECT. We assessed <sup>213</sup>Bi imaging capabilities of the Versatile Emission Computed...journal article 2016